Lymphocyte-activation gene 3 (LAG-3) and T-cell Ig and mucin domain-containing protein 3 (TIM-3) are also attractive immunosuppressive targets being actively investigated in breast cancer. The gene discussed is LAG3; the disease is breast carcinoma.